Dendritic cells and IL-22BP: targets for an innovative immunotherapeutic strategy for the treatment of inflammatory diseases Within the 1064 INSERM... View Article
Author Archives for Adeline Chauvigné
CESTI-IHU: Dendritic cells and IL-22BP: targets for an innovative immunotherapeutic strategy
4 June 2025Dendritic cells and IL-22BP: targets for an innovative immunotherapeutic strategy for the treatment of inflammatory diseases Within the 1064 INSERM... View Article
International master’s degree in Microalgae Bioprocess Engineering in September 2017 (University of Nantes)
Openning in september 2017 ! In September 2017, Nantes University will launch a Master degree in Microalgae Bioprocess Engineering. This Master degree... View Article
International master’s degree in Microalgae Bioprocess Engineering in September 2017 (University of Nantes)
4 June 2025Openning in september 2017 ! In September 2017, Nantes University will launch a Master degree in Microalgae Bioprocess Engineering. This Master degree... View Article
Hemarina announces a fundraising of more than 8M€
Hemarina, the marine Biotechnology company centered on the development of innovative oxygen carriers, announces a fundraising of more than 8M€.... View Article
Hemarina announces a fundraising of more than 8M€
4 June 2025Hemarina, the marine Biotechnology company centered on the development of innovative oxygen carriers, announces a fundraising of more than 8M€.... View Article
The Atlanpole Biotherapies cluster’s confirmed excellence in immunotherapy
The cluster’s success The cluster’s laboratories in fundamental and clinical research in immunotherapy and the companies are excelling in this... View Article
The Atlanpole Biotherapies cluster’s confirmed excellence in immunotherapy
4 June 2025The cluster’s success The cluster’s laboratories in fundamental and clinical research in immunotherapy and the companies are excelling in this... View Article
Atlab Pharma & Telix Pharmaceuticals: agreement for prostate cancer
From Australia to France Atlab Pharma (Nantes, FRANCE) and Telix Pharmaceuticals (Melbourne, AUSTRALIA) conclude a Therapeutic Product Development Agreement for Prostate... View Article
Atlab Pharma & Telix Pharmaceuticals: agreement for prostate cancer
4 June 2025From Australia to France Atlab Pharma (Nantes, FRANCE) and Telix Pharmaceuticals (Melbourne, AUSTRALIA) conclude a Therapeutic Product Development Agreement for Prostate... View Article
OSE Immunotherapeutics: at BIO CEO & Investor Conference, NY, Feb. 13&14, 2017
OSE Immunotherapeutics announced that its management team will present an overview of the Company’s business and will be available to participate in one-on-one meetings with... View Article
OSE Immunotherapeutics: at BIO CEO & Investor Conference, NY, Feb. 13&14, 2017
4 June 2025OSE Immunotherapeutics announced that its management team will present an overview of the Company’s business and will be available to participate in one-on-one meetings with... View Article
InFlectis BioScience: partnership in ophthalmology
InFlectis BioScience & Laboratoire de Génétique Médicale de Strasbourg enter into a strategic partnership in ophthalmology InFlectis BioScience announced... View Article
InFlectis BioScience: partnership in ophthalmology
4 June 2025InFlectis BioScience & Laboratoire de Génétique Médicale de Strasbourg enter into a strategic partnership in ophthalmology InFlectis BioScience announced... View Article
Hemarina: winner of Creative Next contest
New York, NY, February 9, 2016 — Business France, the French national agency supporting the international development of the French economy,... View Article
Hemarina: winner of Creative Next contest
4 June 2025New York, NY, February 9, 2016 — Business France, the French national agency supporting the international development of the French economy,... View Article
ASTATE: SUBJECT OF A CLINICAL STUDY IN NANTES UNIVERSITY HOSPITAL
Astate, so rare and so precious in the treatment of cancer. “It is mysterious, only exists in minute quantities,... View Article
ASTATE: SUBJECT OF A CLINICAL STUDY IN NANTES UNIVERSITY HOSPITAL
4 June 2025Astate, so rare and so precious in the treatment of cancer. “It is mysterious, only exists in minute quantities,... View Article
VALNEVA RECEIVES THE FRENCH “SOCIÉTÉ COTÉE” PRIZE OF THE DELOITTE FAST 50 CONTEST
Valneva SE, a biotechnology company, which is marketing and developing innovative vaccines, announced that they have received the “Société Côtée”... View Article
VALNEVA RECEIVES THE FRENCH “SOCIÉTÉ COTÉE” PRIZE OF THE DELOITTE FAST 50 CONTEST
4 June 2025Valneva SE, a biotechnology company, which is marketing and developing innovative vaccines, announced that they have received the “Société Côtée”... View Article